Abstract | BACKGROUND: METHODS: We retrospectively analyzed all patients treated with VV-ECMO in our University Hospital from 2012 to 2019 (pre-COVID era). Demographic variables, severity scores, MV duration before ECMO, pre and on-ECMO arterial blood gases and respiratory variables were collected. The primary outcome was ICU mortality. Data were compared between survivors and non-survivors, and factors associated with mortality were assessed in univariate and multivariate analyses. RESULTS: Fifty-one patients (33 ARDS, 18 non-ARDS) were included. ICU survival was 49% (ARDS, 39%; non-ARDS 67%). In univariate analyses, a higher driving pressure (DP) at 24h and 48h on ECMO (whole population), longer MV duration before ECMO and higher DP at 24h on ECMO (ARDS patients), were associated with mortality. In multivariate analyses, ECMO indication, higher DP at 24h on ECMO and, in ARDS, longer MV duration before ECMO, were independently associated with mortality. CONCLUSIONS: DP on ECMO and longer MV duration before ECMO (in ARDS) are major, and potentially modifiable, factors influencing outcome during VV-ECMO.
|
Authors | Thomas Orthmann, Zied Ltaief, Jean Bonnemain, Matthias Kirsch, Lise Piquilloud, Lucas Liaudet |
Journal | BMC pulmonary medicine
(BMC Pulm Med)
Vol. 23
Issue 1
Pg. 301
(Aug 16 2023)
ISSN: 1471-2466 [Electronic] England |
PMID | 37587413
(Publication Type: Journal Article)
|
Copyright | © 2023. BioMed Central Ltd., part of Springer Nature. |
Topics |
- Humans
- Extracorporeal Membrane Oxygenation
- COVID-19
- Retrospective Studies
- Blood Gas Analysis
- Respiratory Distress Syndrome
(therapy)
- Respiratory Insufficiency
(therapy)
|